Erlotinib in Advanced Non-small Cell Lung Cancer Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study
Martin Reck, Nico van Zandwijk, Cesare Gridelli, Zoltan Baliko, Danny Rischin, Simon Allan, Maciej Krzakowski, David Heigener
Journal of Thoracic Oncology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2010
Supported by F. Hoffmann-La Roche Ltd. The authors thank all the patients, investigators, and site staff, in addition to the F. Hoffmann-La Roche study team members and monitors who were involved in this study. They also thank Abdul Al Khaleeb of Gardiner-Caldwell Communications for editorial assistance; this support was funded by F. Hoffmann-La Roche.